RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, an amendment to Purchase Order #F09142 with Bio-Rad Laboratories, Inc., to increase the payment limit by $100,000 for a new payment limit of $470,000 for the purchase of reagents and supplies for the D-100 Hemoglobin Testing System at the Contra Costa Regional Medical Center (CCRMC), with no change in the original term of July 1, 2017 through June 30, 2022.
FISCAL IMPACT:
100% funded by the Hospital Enterprise Fund I.
BACKGROUND:
The CCRMC Clinical Laboratory utilizes Bio-Rad Laboratories, Inc. for reagents, various controls, media and supplies for the D-100 Hemoglobin Testing System, which tests for iron deficiency and polycythemia. It is also used for hemoglobin A1C testing in patients with diabetes.
CONSEQUENCE OF NEGATIVE ACTION:
If the amendment to the Purchase Order is not approved, the CCRMC and Clinical Laboratory will not be able to perform patient testing, thus impacting patient safety and health.
|